MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poland, A.
Right arrow Articles by Glover, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poland, A.
Right arrow Articles by Glover, E.

Characterization and strain distribution pattern of the murine Ah receptor specified by the Ahd and Ahb-3 alleles

A Poland and E Glover

McArdle Laboratory for Cancer Research, University of Wisconsin, Madison 53706.

Two allelic forms of the Ah receptor have been previously identified by covalent labeling of the hepatic cytosol fractions of inbred strains of mice with the photoaffinity ligand 2-azido-3-[125I] iodo-7,8- dibromodibenzo-p-dioxin and resolution of the labeled protein by denaturing gel electrophoresis: 1) a Mr 95,000 protein encoded by the Ahb-1 allele carried by the C57 and C58 family of mice, and 2) a Mr 104,000 protein encoded by the Ahb-2 allele present in other common inbred strains that are responsive to aromatic hydrocarbons (e.g., C3H/He, BALB/cBy, and A). In this report, 125I-photoaffinity labeling is used to characterize two further murine variants and the strains that carry them: 1) the low affinity Ah receptor (Ahd allele) in strains that are nonresponsive to aromatic hydrocarbons and 2) a newly identified, high affinity variant (Ahb-3) found in several strains recently derived from feral mice. The low affinity Ah receptor has been recently characterized by reversible ligand binding by Okey et al. [Mol. Pharmacol. 35:823-830 (1989)], through the inclusion of sodium molybdate in the buffers during tissue preparation and ligand incubation to stabilize the receptor. Examination of the Ah receptor in hepatic cytosol from 18 strains of mice carrying the Ahd allele, by preparation in molybdate and photoaffinity labeling, revealed that all strains express a Mr 104,000 protein. Tissue preparation in 20 mM sodium molybdate and subsequent dilution of the molybdate to approximately 0.5 mM during ligand incubation was found to enhance photoaffinity labeling of the high and low affinity allelic forms of the Ah receptor. A new variant of the receptor (Ahb-3) expressing a Mr 105,000 protein was detected in Mus molossinus, hortulanus, pahari, spretus, and caroli but was absent from the strains of Mus musculus or domesticus that were examined. Allelic variants were also distinguishable by thermolability, i.e., the half-life of specific ligand binding capacity upon incubation at 35 degrees. For the Ahb-1 allele (Mr 95,000) the t 1/2 (thermostability) is 20-30 min, for the Ahb-2 allele (Mr 104,000) the t 1/2 is 3-6 min, and for the Ahb-3 allele (Mr 105,000) the thermolability is intermediate.

Volume 38, Issue 3, pp. 306-312, 09/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Toxicol SciHome page
A. B. Okey
An Aryl Hydrocarbon Receptor Odyssey to the Shores of Toxicology: The Deichmann Lecture, International Congress of Toxicology-XI
Toxicol. Sci., July 1, 2007; 98(1): 5 - 38.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. R. Dale and S. E. Eltom
Calpain Mediates the Dioxin-Induced Activation and Down-Regulation of the Aryl Hydrocarbon Receptor
Mol. Pharmacol., November 1, 2006; 70(5): 1481 - 1487.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. S. Pollenz and E. J. Dougherty
Redefining the Role of the Endogenous XAP2 and C-terminal hsp70-interacting Protein on the Endogenous Ah Receptors Expressed in Mouse and Rat Cell Lines
J. Biol. Chem., September 30, 2005; 280(39): 33346 - 33356.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D. F. Staskal, J. J. Diliberto, M. J. DeVito, and L. S. Birnbaum
Inhibition of Human and Rat CYP1A2 by TCDD and Dioxin-like Chemicals
Toxicol. Sci., April 1, 2005; 84(2): 225 - 231.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. L. Thomae, E. A. Stevens, and C. A. Bradfield
Transforming Growth Factor-{beta}3 Restores Fusion in Palatal Shelves Exposed to 2,3,7,8-Tetrachlorodibenzo-p-dioxin
J. Biol. Chem., April 1, 2005; 280(13): 12742 - 12746.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Ramadoss and G. H. Perdew
Use of 2-Azido-3-[125I]iodo-7,8-dibromodibenzo-p-dioxin as a Probe to Determine the Relative Ligand Affinity of Human versus Mouse Aryl Hydrocarbon Receptor in Cultured Cells
Mol. Pharmacol., July 1, 2004; 66(1): 129 - 136.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Moriguchi, H. Motohashi, T. Hosoya, O. Nakajima, S. Takahashi, S. Ohsako, Y. Aoki, N. Nishimura, C. Tohyama, Y. Fujii-Kuriyama, et al.
Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse
PNAS, May 13, 2003; 100(10): 5652 - 5657.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. W. Robinson, B. Clothier, R. A. Akhtar, A. L. Yang, I. Latour, C. Van Ijperen, M. F. W. Festing, and A. G. Smith
Non-Ahr Gene Susceptibility Loci for Porphyria and Liver Injury Induced by the Interaction of `Dioxin' with Iron Overload in Mice
Mol. Pharmacol., March 1, 2002; 61(3): 674 - 681.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. E. Akiyama, C. J. Nicol, C. Fievet, B. Staels, J. M. Ward, J. Auwerx, S. S. T. Lee, F. J. Gonzalez, and J. M. Peters
Peroxisome Proliferator-activated Receptor-alpha Regulates Lipid Homeostasis, but Is Not Associated with Obesity. STUDIES WITH CONGENIC MOUSE LINES
J. Biol. Chem., October 12, 2001; 276(42): 39088 - 39093.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Vogel, A.-M. J.F. Boerboom, C. Baechle, C. El-Bahay, R. Kahl, G. H. Degen, and J. Abel
Regulation of prostaglandin endoperoxide H synthase-2 induction by dioxin in rat hepatocytes: possible c-Src-mediated pathway
Carcinogenesis, December 1, 2000; 21(12): 2267 - 2274.
[Abstract] [Full Text] [PDF]


Home page
Toxicol Ind HealthHome page
Regulations and Advisories
Toxicology and Industrial Health, April 1, 2000; 16(3-5): 173 - 201.
[PDF]


Home page
Mol. Pharmacol.Home page
R. S. Pollenz, N. A. Davarinos, and T. P. Shearer
Analysis of Aryl Hydrocarbon Receptor-Mediated Signaling during Physiological Hypoxia Reveals Lack of Competition for the Aryl Hydrocarbon Nuclear Translocator Transcription Factor
Mol. Pharmacol., December 1, 1999; 56(6): 1127 - 1137.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
C. E. W. Sulentic, M. P. Holsapple, and N. E. Kaminski
Aryl Hydrocarbon Receptor-Dependent Suppression by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of IgM Secretion in Activated B Cells
Mol. Pharmacol., April 1, 1998; 53(4): 623 - 629.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
A. G. Smith, B. Clothier, S. Robinson, M. J. Scullion, P. Carthew, R. Edwards, J. Luo, C. K. Lim, and M. Toledano
Interaction between Iron Metabolism and 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Mice with Variants of the Ahr Gene: A Hepatic Oxidative Mechanism
Mol. Pharmacol., January 1, 1998; 53(1): 52 - 61.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. S. Pollenz, H. R. Sullivan, J. Holmes, B. Necela, and R. E. Peterson
Isolation and Expression of cDNAs from Rainbow Trout (Oncorhynchus mykiss) That Encode Two Novel Basic Helix-Loop-Helix/PER-ARNT-SIM (bHLH/PAS) Proteins with Distinct Functions in the Presence of the Aryl Hydrocarbon Receptor. EVIDENCE FOR ALTERNATIVE mRNA SPLICING AND DOMINANT NEGATIVE ACTIVITY IN THE bHLH/PAS FAMILY
J. Biol. Chem., November 29, 1996; 271(48): 30886 - 30896.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics